Safety and Tolerability Study of NMN in DHDDS-CDG Patients Initiated
A clinical trial has been initiated to assess the safety and tolerability of NMN in patients with DHDDS-CDG.
Company
Pharmaceutical intelligence for DHDDS-CDG with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.